SOLICITATION NOTICE
66 -- Clinical Molecular Profiling Core & Installation
- Notice Date
- 8/13/2008
- Notice Type
- Presolicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd., EPS Suite 600, Rockville, Maryland, 20852
- ZIP Code
- 20852
- Solicitation Number
- NCI-80177_NG
- Archive Date
- 9/12/2008
- Point of Contact
- Ashley L. Virts, , Malinda L Holdcraft,, Phone: (301) 402-4509
- E-Mail Address
-
virtsa@mail.nih.gov, holdcram@exchange.nih.gov
- Small Business Set-Aside
- N/A
- Description
- The National Cancer Institute (NCI), Clinical Molecular Profiling Core and installation (CMPC) plans to procure as a sole source the brand QIAcube and QIAxcel Instruments with Qiagen Inc.; 27220 Turnberry Ln., Suite 200; Valencia, California 91355-1005. The supplies are herein are being procured in accordance with the simplified acquisition procedures authorized by FAR Part 13.106-(b) (1). The North American Industry Classification System Code is 334516 and the business size standard is 500 employees. Part I. Background Information and Description of Acquisition: The Clinical Molecular Profiling Core (CMPC) will develop and implement state of the art genomic technologies thereby maximizing the clinical benefits and biological insights derived from the analysis of biospecimens obtained from the NCI clinical trials. The purchase of the QIAcube and QIAxcel instruments will allow CMPC to employ state of the art technology for the processing and analysis of human subject’s specimens derived from these trials for specific downstream nucleic acids applications. Specifically, the QIAcube is an automated mechanism for increased throughput of patient specimen processing for the purification of DNA, RNA, and proteins. The QIAxcel system enables fully automated high resolution capillary electrophoresis for up to 96 samples per run allowing for high throughput quality control analyses of extracted DNA, RNA and PCR products. Part II. Facts and Reasons to Justify Other than Full and Open Competition: Statute: This justification has been prepared under the authority of 41 U.S.C. 253 (c)(1) as set forth in 13.106-1 (b)(1). (b) Soliciting from a single source. (1) For purchases not exceeding the simplified acquisition threshold, contracting officers may solicit from one source if the contracting officer determines that the circumstances of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, or industrial mobilization). No other requirement and/or type for supply or service will satisfy agency need. The QIAcube is designed to perform fully automated purification of nucleic acids and proteins of up to 12 samples per run for use in molecular biology applications. The QIAcube uses proven QIAGEN® spin-column technology currently employed in the CMPC and is the only known robotic instrument to do so. Uniquely, the instrument controls integrated components including a centrifuge, heated shaker, pipetting system, and robotic gripper minimizing technician hands-on time and creating an efficient workflow for core specimen processing. The CMPC will be CLIA certified and the fact that accessories fit on the worktable only in the correct orientation is critical for the quality measures the core needs to take. The QIAxcel system enables fully automated and sensitive, high-resolution capillary electrophoresis for up to 96 samples per run. The high through put enables the CMPC to quickly and accurately obtain quality control measures for extracted DNA and RNA. The ready-to-run gel cartridges contain 12 separation micro-channels with a built-in gel matrix for fast, high-resolution of DNA fragments or RNA separation. No other source is known to the NCI that can perform the operations of the QIAcube and the QIAxcel, especially at the cost quoted by the vendor and with the small space saving footprints of these instruments. This is not a request for competitive quotation. However, if any interested party believes it can meet the above requirements, it may submit a statement of capabilities. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow the researcher to determine if the party can meet these requirements. One (1) original and one (1) copy of the capability statement must be received in the contracting office by 11:00 a.m. ET on August 28, 2008. All questions must be in writing and can be faxed to 301-402-4513 or sent via email to Malinda Holdcraft: holdcram@exchange.nih.gov. It is the vendor’s responsibility to ensure questions have been received. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. In order to receive an award, contractor must have valid, updated registration and certification in the Central Contractor Registration (CCR) and the Online Representations and Certifications Application (ORCA). Please reference NCI-80177-NG on all correspondence.
- Web Link
-
FedBizOpps Complete View
(https://www.fbo.gov/?s=opportunity&mode=form&id=940a7d3a7360f94038e0b207987f39e8&tab=core&_cview=1)
- Record
- SN01639362-W 20080815/080813223910-940a7d3a7360f94038e0b207987f39e8 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |